Ola Weiland : rechercher sur Z-Library

Le plus grand référentiel d'articles scientifiques au monde. 70,000,000+ d'articles gratuitement.

Don't use scam websites

Livres
Articles (159)
Les plus populaires
Liste
- Liste
- Tableau

1

Editorial - An introduction to the new INFECTIOUS DISEASES

Tärnvik, Arne, Weiland, Ola

Journal:

Scandinavian Journal of Infectious Diseases

Année:

2014

Langue:

english

Fichier:

PDF, 430 KB

english, 2014

2

Staphylococcus aureus bacteraemia and endocarditis – epidemiology and outcome: a review

Asgeirsson, Hilmir, Thalme, Anders, Weiland, Ola

Journal:

Infectious Diseases

Année:

2017

Langue:

english

Fichier:

PDF, 1.63 MB

english, 2017

3

Heterosexual contact as a major route for transmission of acute hepatitis B among adults

Johan Struve, Johan Giesecke, Gudrun Lindh, Ola Weiland

Journal:

Journal of Infection

Année:

1990

Langue:

english

Fichier:

PDF, 612 KB

english, 1990

4

GBV-C/HGV infection in hepatitis C virus-infected deferred Swedish blood donors

Shev, Steven, Björkman, Per, Norkrans, Gunnar, Foberg, Ulla, Frydén, Aril, Lindh, Gudrun, Lindholm, Annika, Weiland, Ola, Widell, Anders

Journal:

Journal of Medical Virology

Année:

1998

Langue:

english

Fichier:

PDF, 40 KB

english, 1998

5

Variation in the hepatitis C virus NS5a region in relation to hypervariable region 1 heterogeneity during interferon treatment

Odeberg, Jacob, Yun, Zhibing, Sönnerborg, Anders, Weiland, Ola, Lundeberg, Joakim

Journal:

Journal of Medical Virology

Année:

1998

Langue:

english

Fichier:

PDF, 146 KB

english, 1998

6

Humoral and cellular immune responses to the GB virus C/hepatitis G virus envelope 2 protein

Una Lazdina, Catharina Hultgren, Margaret Chen, Björn Fischler, Ola Weiland, Isa K. Mushahwar, Matti Sällberg

Journal:

Journal of Medical Virology

Année:

2000

Langue:

english

Fichier:

PDF, 655 KB

english, 2000

7

The application of a numerical scoring system for evaluating the histological outcome in patients with chronic hepatitis B followed in long term

Gudrun Lindh, Ola Weiland, Hans Glaumann

Journal:

Année:

1988

Langue:

english

Fichier:

PDF, 645 KB

english, 1988

8

High sustained response rate and clearance of viremia in chronic hepatitis C after treatment with interferon-α2b for 60 weeks

Olle Reichard, Ulla Foberg, Aril Frydén, Lars Mattsson, Gunnar Norkrans, Anders Sönnerborg, Rune Wejstål, Zhi-Bing Yun, Ola Weiland

Journal:

Année:

1994

Langue:

english

Fichier:

PDF, 619 KB

english, 1994

9

Two-year biochemical, virological, and histological follow-up in patients with chronic hepatitis C responding in a sustained fashion to interferon alfa-2b treatment

Olle Reichard, Hans Glaumann, Aril Frydén, Gunnar Norkrans, Robert Schvarcz, Anders Sönnerborg, Zhi-Bing Yun, Ola Weiland

Journal:

Année:

1995

Langue:

english

Fichier:

PDF, 551 KB

english, 1995

10

Human and murine antibody recognition is focused on the ATPase/Helicase, but not the protease domain of the hepatitis C virus nonstructural 3 protein

Margaret Chen, Matti Sällberg, Anders Sönnerborg, Ling Jin, Ashley Birkett, Darrell Peterson, Ola Weiland, David R. Milich

Journal:

Année:

1998

Langue:

english

Fichier:

PDF, 121 KB

english, 1998

11

Immunoglobulin isotypes of anti-HBc and anti-HBe and hepatitis B virus (HBV) DNA elimination in acute hepatitis B

Matti Sällberg, Helen Norder, Ola Weiland, Lars Magnius

Journal:

Journal of Medical Virology

Année:

1989

Langue:

english

Fichier:

PDF, 773 KB

english, 1989

12

Detection of hepatitis C virus (HCV) RNA by PCR related to HCV antibodies in serum and liver histology in swedish blood donors

Zhi-Bing Yun, Gudrun Lindh, Ola Weiland, Bo Johansson, Dr. Anders Sönnerborg

Journal:

Journal of Medical Virology

Année:

1993

Langue:

english

Fichier:

PDF, 505 KB

english, 1993

13

Hepatitis C viral RNA titers in serum prior to, during, and after oral treatment with ribavirin for chronic hepatitis C

Dr. Olle Reichard, Zhi-Bing Yun, Anders Sönnerborg, Ola Weiland

Journal:

Journal of Medical Virology

Année:

1993

Langue:

english

Fichier:

PDF, 408 KB

english, 1993

14

Genotyping of hepatitis C virus isolates by a modified polymerase chain reaction assay using type specific primers: Epidemiological applications

Dr. Anders Widell, Steven Shev, Siv Månsson, Yong-Yuan Zhang, Ulla Foberg, Gunnar Norkrans, Aril Frydén, Ola Weiland, Jan Kurkus, Erik Nordenfelt

Journal:

Journal of Medical Virology

Année:

1994

Langue:

english

Fichier:

PDF, 804 KB

english, 1994

15

Serum levels of anti-NS4a and anti-NS5a predict treatment response of patients with chronic hepatitis C

Isabelle Desombere, Hans Van Vlierberghe, Ola Weiland, Catharina Hultgren, Matti Sällberg, Juan Quiroga, Vicente Carreño, Geert Leroux-Roels

Journal:

Journal of Medical Virology

Année:

2007

Langue:

english

Fichier:

PDF, 321 KB

english, 2007

16

Rapid viral response and treatment outcome in genotype 2 and 3 chronic hepatitis C: comparison between two HCV RNA quantitation methods

Tony Carlsson, Anne Quist, Ola Weiland

Journal:

Journal of Medical Virology

Année:

2008

Langue:

english

Fichier:

PDF, 107 KB

english, 2008

17

Lactobacillus plantarum endocarditis in a patient with benign monoclonal gammopathy

Johan Struve, Ola Weiland, Carl Erik Nord

Journal:

Journal of Infection

Année:

1988

Langue:

english

Fichier:

PDF, 247 KB

english, 1988

18

Risk factors for hepatitis A, B and C virus infection among Swedish expatriates

Johan Struve, Olle Norrbohm, Johan Stenbeck, Johan Giesecke, Ola Weiland

Journal:

Journal of Infection

Année:

1995

Langue:

english

Fichier:

PDF, 466 KB

english, 1995

19

Utility of an anonymous questionnaire for the identification of a primary transmission route and possible secondary transmission in adults with acute hepatitis B virus infection

Johan Struve, Johan Giesecke, Gudrun Lindh, Ola Weiland

Journal:

European Journal of Epidemiology

Année:

1996

Langue:

english

Fichier:

PDF, 386 KB

english, 1996

20

Response to a booster dose 18 months after a low anti-HBs response (10–99 IU/l) to three doses of intradermally or intramuscularly administered recombinant hepatitis B vaccine

J. Struve, Ola Weiland, Marianne Fosgren, B. Aronsson, B. Frenning

Journal:

Année:

1995

Langue:

english

Fichier:

PDF, 686 KB

english, 1995

21

Treatment of chronic replicative hepatitis B virus infection with short-term continuous infusion of foscarnet

R. Schvarcz, Ola Weiland, B. G. Hansson, J. -O. Lernestedt

Journal:

Année:

1994

Langue:

english

Fichier:

PDF, 474 KB

english, 1994

22

Interferon therapy in chronic hepatitis C virus infection

Journal:

FEMS Microbiology Reviews

Année:

1994

Langue:

english

Fichier:

PDF, 742 KB

english, 1994

23

Predictive value of ALT levels for histologic findings in chronic hepatitis C: A European collaborative study

Pierre Pradat, Alfredo Alberti, Thierry Poynard, Juan-Ignacio Esteban, Ola Weiland, Patrick Marcellin, Salvatore Badalamenti, Christian Trépo

Journal:

Année:

2002

Langue:

english

Fichier:

PDF, 95 KB

english, 2002

24

Chronic non-A, non-B hepatitis developed after transfusions, illicit self-injections or sporadically. Outcome during long-term follow-up – a comparison

Lars Mattsson, Ola Weiland, Hans Glaumann

Journal:

Liver International

Année:

1989

Langue:

english

Fichier:

PDF, 530 KB

english, 1989

25

Long-term follow-up of chronic post-transfusion non-A, non-B hepatitis: clinical and histological outcome

Lars Mattsson, Ola Weiland, Hans Glaumann

Journal:

Liver International

Année:

1988

Langue:

english

Fichier:

PDF, 328 KB

english, 1988

26

Histological outcome in interferon alpha-2b treated patients with chronic posttransfusion non-A, non-B hepatitis

Robert Schvarcz, Hans Glaumann, Ola Weiland, Gunnar Norkrans, Rune Wejstål, Aril Frydén

Journal:

Liver International

Année:

1991

Langue:

english

Fichier:

PDF, 916 KB

english, 1991

27

Application of a numerical scoring system for assessment of histological outcome in patients with chronic posttransfusion non-A, non-B hepatitis with or without antibodies to hepatitis C

Lars Mattsson, Ola Weiland, Hans Glaumann

Journal:

Liver International

Année:

1990

Langue:

english

Fichier:

PDF, 434 KB

english, 1990

28

Peripheral blood lymphocyte subsets in patients with chronic hepatitis C – effects of interferon treatment

Rune Wejstàl, Gunnar Norkrans, Rodiça Lenkei, Ola Weiland, Robert Schvarcz, Aril Frydén

Journal:

Liver International

Année:

1992

Langue:

english

Fichier:

PDF, 519 KB

english, 1992

29

Outcome of acute symptomatic non-A, non-B hepatitis: a 13-year follow-up study of hepatitis C virus markers

Lars Mattsson, Anders Sönnerborg, Ola Weiland

Journal:

Liver International

Année:

1993

Langue:

english

Fichier:

PDF, 451 KB

english, 1993

30

Histological outcome in patients with chronic hepatitis C given a 60-week interferon alfa-2b treatment course

Olle Reichard, Hans Glauman, Gunnar Norkrans, Rune Wejstål, Aril Fryden, Robert Schvarcz, Ola Weiland

Journal:

Liver International

Année:

1994

Langue:

english

Fichier:

PDF, 524 KB

english, 1994

31

Hepatitis C: Virology, Epidemiology, Clinical Course, and Treatment

Weiland, Ola, Schvarcz, Robert

Journal:

Scandinavian Journal of Gastroenterology

Année:

1992

Langue:

english

Fichier:

PDF, 705 KB

english, 1992

32

Evidence for a relation between the viral load and genotype and hepatitis C virus-specific T cell responses

Catharina Hultgren, Isabelle Desombere, Geert Leroux-Roels, Juan A Quiroga, Vincente Carreno, Bo Nilsson, Ola Weiland, Matti Sällberg

Journal:

Journal of Hepatology

Année:

2004

Langue:

english

Fichier:

PDF, 244 KB

english, 2004

33

SHORT STATEMENT OF THE FIRST EUROPEAN CONSENSUS CONFERENCE ON THE TREATMENT OF CHRONIC HEPATITIS B AND C IN HIV CO-INFECTED PATIENTS

Alfredo Alberti, Nathan Clumeck, Simon Collins, Wolfram Gerlich, Jens Lundgren, Giorgio Palù, Peter Reiss, Rodolphe Thiebaut, Ola Weiland, Yazdan Yazdanpanah, Stefan Zeuzem, (The ECC Jury)

Journal:

Journal of Hepatology

Année:

2005

Langue:

english

Fichier:

PDF, 140 KB

english, 2005

34

Corrigendum to “SHORT STATEMENT OF THE FIRST EUROPEAN CONSENSUS CONFERENCE ON THE TREATMENT OF CHRONIC HEPATITIS B AND C IN HIV CO-INFECTED PATIENTS”[J Hepatol 42 (2005) 615–624]

Alfredo Alberti, Nathan Clumeck, Simon Collins, Wolfram Gerlich, Jens Lundgren, Giorgio Palù, Peter Reiss, Rodolphe Thiebaut, Ola Weiland, Yazdan Yazdanpanah, Stefan Zeuzem (The ECC Jury)

Journal:

Journal of Hepatology

Année:

2005

Langue:

english

Fichier:

PDF, 39 KB

english, 2005

35

Efficacy of 24 weeks treatment with peginterferon alfa-2b plus ribavirin in patients with chronic hepatitis C infected with genotype 1 and low pretreatment viremia

Stefan Zeuzem, Maria Buti, Peter Ferenci, Jan Sperl, Yves Horsmans, Janusz Cianciara, Endre Ibranyi, Ola Weiland, Stephanie Noviello, Clifford Brass, Janice Albrecht

Journal:

Journal of Hepatology

Année:

2006

Langue:

english

Fichier:

PDF, 116 KB

english, 2006

36

Hepatic and extrahepatic malignancies in autoimmune hepatitis. A long-term follow-up in 473 Swedish patients

Mårten Werner, Sven Almer, Hanne Prytz, Stefan Lindgren, Sven Wallerstedt, Einar Björnsson, Annika Bergquist, Hanna Sandberg-Gertzén, Rolf Hultcrantz, Per Sangfelt, Ola Weiland, Åke Danielsson

Journal:

Journal of Hepatology

Année:

2009

Langue:

english

Fichier:

PDF, 112 KB

english, 2009

37

What offers the best prediction of sustained virologic response during combination therapy with interferon and ribavirin: Viral dynamics, viral levels at certain time points, or a combination of both?

Journal:

Journal of Hepatology

Année:

2009

Langue:

english

Fichier:

PDF, 91 KB

english, 2009

38

Stimulation of human peripheral blood lymphocytes by autologous EBV-infected B cells

Jean Viallat, Erik Svedmyr, Eitan Yefenof, George Klein, Ola Weiland

Journal:

Cellular Immunology

Année:

1978

Langue:

english

Fichier:

PDF, 471 KB

english, 1978

39

FGFR2 mutations and acne Can HCV infection be cleared?

Journal:

Année:

1998

Langue:

english

Fichier:

PDF, 26 KB

english, 1998

40

Randomised, double-blind, placebo-controlled trial of interferon α-2b with and without ribavirin for chronic hepatitis C

Olle Reichard, Gunnar Norkrans, Aril Frydén, Jean-Henrik Braconier, Anders Sönnerborg, Ola Weiland

Journal:

Année:

1998

Langue:

english

Fichier:

PDF, 77 KB

english, 1998

41

Should hepatitis B vaccination be introduced into childhood immunisation programmes in northern Europe?

Jane Zuckerman, Jan van Hattum, Mary Cafferkey, Ida Gj⊘rup, Terje Hoel, Maija-Liisa Rummukainen, Ola Weiland

Journal:

The Lancet Infectious Diseases

Année:

2007

Langue:

english

Fichier:

PDF, 556 KB

english, 2007

42

Virologic, immunologic, and clinical observations on a patient during the incubation, acute, and convalescent phases of infectious mononucleosis

Erik Svedmyr, Ingemar Ernberg, Janet Seeley, Ola Weiland, Giuseppe Masucci, Koji Tsukuda, Robert Szigeti, Maria Grazia Masucci, Henric Blomgren, Wolfgang Berthold, Werner Henle, George Klein

Journal:

Clinical Immunology and Immunopathology

Année:

1984

Langue:

english

Fichier:

PDF, 906 KB

english, 1984

43

Epstein-Barr virus (EBV) antigen-specific leukocyte migration inhibition (LMI) in infectious mononucleosis (IM): I. Kinetics and response to a membrane protein on EBV-transformed cells

Robert Szigeti, Laszlo Timar, Ola Weiland, Werner Henle, Gertrude Henle, Kevin Hennessy, Elliott Kieff, Dov Sulitzeanu, Joakim Dillner, George Klein

Journal:

Clinical Immunology and Immunopathology

Année:

1986

Langue:

english

Fichier:

PDF, 548 KB

english, 1986

44

Limited humoral immunity in hepatitis C virus infection

Margaret Chen, Matti Sällberg, Anders Sönnerborg, Ola Weiland, Lars Mattsson, Ling Jin, Ashley Birkett, Darrell Peterson, David R. Milich

Journal:

Gastroenterology

Année:

1999

Langue:

english

Fichier:

PDF, 136 KB

english, 1999

45

Survival and histological resolution of fibrosis in patients with autoimmune chronic active hepatitis

Robert Schvarcz, Hans Glaumann, Ola Weiland

Journal:

Journal of Hepatology

Année:

1993

Langue:

english

Fichier:

PDF, 12.10 MB

english, 1993

46

Long-term follow-up of chronic hepatitis C patients with sustained virological response to alpha-interferon

Olle Reichard, Hans Glaumann, Aril Frydén, Gunnar Norkrans, Rune Wejstål, Ola Weiland

Journal:

Journal of Hepatology

Année:

1999

Langue:

english

Fichier:

PDF, 621 KB

english, 1999

47

Treatment of naive patients with chronic hepatitis C

Journal:

Journal of Hepatology

Année:

1999

Langue:

english

Fichier:

PDF, 658 KB

english, 1999

48

IgM-antibody response to hepatitis C virus antigens in acute and chronic post-transfusion non-A, non-B hepatitis

Kurt H. Chau, George J. Dawson, Isa K. Mushahwar, Robin A. Gutierrez, Rhonda G. Johnson, Richard R. Lesniewski, Lars Mattsson, Ola Weiland

Journal:

Journal of Virological Methods

Année:

1991

Langue:

english

Fichier:

PDF, 596 KB

english, 1991

49

Detection of hepatitis C viral RNA by the polymerase chain reaction in serum of patients with post-transfusion non-A, non-B hepatitis

George G. Schlauder, Gail J. Leverenz, Lars Mattsson, Ola Weiland, Isa K. Mushahwar

Journal:

Journal of Virological Methods

Année:

1992

Langue:

english

Fichier:

PDF, 994 KB

english, 1992

50

Colorimetric detection of competitive PCR products for quantification of hepatities C viremia

Zhibing Yun, Joakim Lundeberg, Bo Johansson, Anders Hedrum, Ola Weiland, Mathias Uhlén, Anders Sönnerborg

Journal:

Journal of Virological Methods

Année:

1994

Langue:

english

Fichier:

PDF, 861 KB

english, 1994